Keywords: roche, valcyte, comparable, cytovene, results, 12-month, pivotal

Roche's Valcyte comparable to Cytovene

Article | 09 June 2003

Print This

Results from a 12-month pivotal Phase III study show that Roche's Valcyte (valganciclovir) is as effective as Cytovene (ganciclovir) in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in